How to finance national antimicrobial resistance action plans
Bull World Health Organ
.
2024 May 1;102(5):370-372.
doi: 10.2471/BLT.24.291638.
Epub 2024 Mar 27.
Authors
Serife Genc Ileri
1
,
Ritu Sadana
2
,
Anand Balachandran
3
Affiliations
1
Department of Economics, Faculty of Management, Istanbul Technical University, Macka Campus, 34367 Macka Istanbul, Türkiye.
2
Secretariat, WHO Council on the Economics of Health for All, World Health Organization, Geneva, Switzerland.
3
Surveillance, Prevention and Control Department, World Health Organization, Geneva, Switzerland.
PMID:
38680462
PMCID:
PMC11046159
DOI:
10.2471/BLT.24.291638
No abstract available
MeSH terms
Anti-Bacterial Agents / economics
Anti-Bacterial Agents / pharmacology
Drug Resistance, Bacterial*
Drug Resistance, Microbial
Global Health
Humans
World Health Organization
Substances
Anti-Bacterial Agents
Grants and funding
001/WHO_/World Health Organization/International